Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - BIOFIELD CORP \DE\ | c93952exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - BIOFIELD CORP \DE\ | c93952exv31w1.htm |
EX-31.2 - EXHIBIT 31.2 - BIOFIELD CORP \DE\ | c93952exv31w2.htm |
EX-32.2 - EXHIBIT 32.2 - BIOFIELD CORP \DE\ | c93952exv32w2.htm |
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1
to
to
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2009
Commission File No: 0-27848
BIOFIELD CORP.
(Name of registrant in its charter)
Delaware | 13-3703450 | |
(State of other jurisdiction of Incorporation or Organization) | (Employer Identification Number) | |
1615 Walnut Street, 3 rd Floor, Philadelphia, PA | 19102 | |
(Address of principal executive offices) | (Zip Code) |
(215) 972-1717
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 30 days: Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes o
No þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer or a smaller reporting company. See definition of accelerated filer and large
accelerated filer in Rule 12b-12 of the Exchange Act (Check one):
Large Accelerated Filer o | Accelerated Filer o | Non-Accelerated Filer o (Do not check if a smaller reporting company) | Smaller Reporting Company þ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act. Yes o No þ
AS OF MAY 8, 2009, THERE WERE 28,486,833 SHARES OF COMMON STOCK OUTSTANDING AND 12,300,000 SHARES
OF VOTING PREFERRED STOCK OUTSTANDING.
EXPLANATORY NOTE
Biofield Corp. (the Company) is filing this Amendment No. 1 to its Quarterly Report on Form
10-Q/A for the quarter ended March 31, 2009, which was originally filed with the Securities and
Exchange Commission (SEC) on May 15, 2009 (the original Form 10-Q), to include new
certifications as exhibits 31.1, 31.2, 32.1 and 32.2 by our principal executive officer and
principal financial officer as required by Rules 12b-15 and 13a-14 promulgated under the Securities
Exchange Act of 1934, as amended (the Exchange Act).
Except for the amended disclosures and reclassification described above, the information in this
Form 10-Q/A has not been updated to reflect events that occurred after May 15, 2009, the filing
date of our original Form 10-Q. Accordingly, this Form 10-Q/A should be read in conjunction with
our filings made with the SEC subsequent to the filing of the original Form 10-Q, including any
amendments to those filings.
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be
signed on its behalf by the undersigned, there unto duly authorized.
BIOFIELD CORP. |
||||
Date: December 22, 2009 | By: | /s/ David Bruce Hong | ||
David Bruce Hong | ||||
Chief Executive Officer | ||||
By: | /s/ David Bruce Hong | |||
David Bruce Hong | ||||
Chief Financial Officer | ||||